Clinical Trial Update: Evaluation of Safety and Efficacy of PDP-716 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating PDP-716 for open angle glaucoma and ocular hypertension has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• PDP-716

Snippet

Sponsor: Sun Pharma Advanced Research Company Limited | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2022-02-15